Control of autophagy in parkinson’s disease

1Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Parkinson’s disease (PD) is a neurodegenerative disorder characterized by a dysregulation of cellular degradation system. An accumulation of misfolded proteins has been founded in the brains of parkinsonian patients, causing neuroinflammation and oxidative stress, and leading to a progressive neurodegeneration. Autophagy plays an important role in the progression of PD. In this chapter, we analyze the relationship of different types of autophagy (microautophagy, chaperone- mediated autophagy (CMA) and macroautophagy) with the oxidative stress and with several proteins involved in PD, showing deregulation of these degradative processes when these proteins are mutated. Also, we show a possible therapeutic alternative based on autophagy inducers that might be a potential drug for PD treatment.

Cite

CITATION STYLE

APA

González-Polo, R. A., Gómez-Sánchez, R., Pizarro-Estrella, E., Yakhine-Diop, S. M. S., Rodríguez-Arribas, M., & Fuentes, J. M. (2015). Control of autophagy in parkinson’s disease. In Toxicity and Autophagy in Neurodegenerative Disorders (pp. 91–122). Springer International Publishing. https://doi.org/10.1007/978-3-319-13939-5_6

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free